The stock price for Cabaletta Bio Inc. (CABA) currently stands at $18.65. The stock experienced a substantial increase in the last session, hitting $19.34 after starting at $16.17. The stock’s lowest price was $16.03 before closing at $15.81.
Cabaletta Bio Inc. saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $16.78 on 09/18/23, while the lowest price for the same duration was marked at $0.59 on 09/23/22.
52-week price history of CABA Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Cabaletta Bio Inc.’s current trading price is 11.14% away from its 52-week high, while its distance from the 52-week low is 3061.02%. The stock’s price range during this period has spanned from $0.59 to $16.78. In the Healthcare sector, the Cabaletta Bio Inc.’s shares surpassed a trading volume of approximately 1.76 million for the day, which was noticeably higher compared to the average daily volume of 9.0.64 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Cabaletta Bio Inc. (CABA) has experienced a quarterly rise of 42.15% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 693.59M and boasts a workforce of 77 employees.
A Closer Look at Analysts’ Ratings for Cabaletta Bio Inc.
As of right now, 5 analysts are rating Cabaletta Bio Inc. as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 12.62, with a change in price of +10.57. Similarly, Cabaletta Bio Inc. recorded 567,833 in trading volume during the last 100 days, posting a change of +130.82%.
Examining CABA’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for CABA stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
CABA Stock Stochastic Average
Today’s raw stochastic average for Cabaletta Bio Inc. over the last 50 days is 91.05%.This indicates a increase from the raw stochastic average of the past 20 days, which was 89.67%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 76.61% and 70.43%, respectively.
CABA Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. This year’s metric has recorded a Price increase of 101.62%. However, over the past six months, we’ve seen a weaker performance of 130.25%. The price of CABA fallen by 52.87% over the last 30 days. And in the last five days, it has surged by 22.46%.